State Funeral of Queen Elizabeth II Bank Holiday Opening Hours

To help keep our customers informed of changes to our service, we have published our Bank Holiday opening hours for the State Funeral of Queen Elizabeth II being held on Monday 19 September 2022.

View our Bank Holiday opening hours:

State Funeral of Queen Elizabeth II Bank Holiday opening hours for Pharmacy and Retail customers

State Funeral of Queen Elizabeth II Bank Holiday opening hours for Hospital customers

Class 4 Medicines Defect Information: PI Bezalip Mono 400mg Tablets (30)

Quadrant Pharmaceuticals Limited have informed the MHRA of an error with the Patient Information Leaflets (PILs) that have been packaged in various parallel imported batches.

MHRA drug alert date:  12 September 2022

MHRA drug alert link: 

https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-quadrant-pharmaceuticals-limited-bezalip-mono-400mg-tablets-el-22-a-slash-38?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=c4d6884b-4d39-4d67-851d-d24ae91bb6dc&utm_content=immediately

This is a caution in use only we are not accepting stock returns - if any defective stock is found it should be returned directly to the manufacturer.

Further Information

For more information, medical or supply enquiries, please contact radoslaw.bandomir@maxearn.co.uk or natalie.harrison@hallohealthcaregroup.com

Recipients of this Medicines Notification should bring it to the attention of relevant contacts by copy of this notice. NHS regional teams are asked to forward this to community pharmacists and dispensing general practitioners for information.

Zentiva Branded Medical RWA

We are pleased to announce that, as of 01 October 2022, Alliance Healthcare UK will become one of the chosen wholesalers to supply Zentiva’s branded medical product portfolio to all pharmacies, hospitals, and dispensing doctors in the United Kingdom.

A full list of Zentiva’s branded medical product portfolio is available here.

Class 2 Recall - Lorazepam 2mg/ml Injection, Lorazepam 4mg/ml Injection (unlicensed medicines)

Hikma Pharmaceuticals USA Inc are recalling the above batches due to an out of specification result with related substances during testing for retain samples. This unlicensed medicine has been imported into the U.K. to meet the special need of individual patients.

MHRA drug alert date: 30 August 2022

MHRA drug alert link:

https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-hikma-pharmaceuticals-usa-inc-lorazepam-2mg-slash-ml-injection-lorazepam-4mg-slash-ml-injection-unlicensed-medicines?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=7ee36a17-10d8-4ee0-9c10-11b3163d55c3&utm_content=immediately

Alliance do not stock the above products so we will not be accepting Customer returns on this recall.

Further Information

For more information or medical enquiries, please contact pv@hikma.com

Recipients of this Medicines Recall should bring it to the attention of relevant contacts by copy of this notice. NHS regional teams are asked to forward this to community pharmacists and dispensing general practitioners for information.

Class 2 Recall - Dysport 500 Units Powder for Solution for Injection

The Medicines and Healthcare products Regulatory Agency (MHRA) has been investigating a report of a falsification of the above product in the UK. The UK Marketing Authorisation Holder has confirmed that the batch above is falsified and has been supplied by unauthorised distributors to the UK.

MHRA drug alert date: 22 August 2022

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-dysport-500-units-powder-for-solution-for-injection-el-22-a-slash-36?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=c9c55a5d-d085-47ca-ac0a-6898ac48c6e8&utm_content=immediately

Alliance do not stock the above product so we will not be accepting Customer returns on this recall.

Further Information

For medical information enquiries, please contact Ipsen Limited at medinfo.uk-ie@ipsen.com

Recipients of this Medicines Recall should bring it to the attention of relevant contacts by copy of this notice. NHS regional teams are asked to forward this to community pharmacists and dispensing general practitioners for information.

Class 4 Medicines Defect Information, Rosuvastatin 5 mg, 10 mg and 20 mg film-coated tablets

Further to a previous defect notification, Accord Healthcare have informed us of an error with the patient information leaflets (PILs) that have been packaged in the below additional batches of products. These were an older version of the PIL which did not include the most up to date safety information.

MHRA drug alert date: 17 August 2022

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-rosuvastatin-5-mg-10-mg-and-20-mg-film-coated-tablets-el-22-a-slash-35?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=2afcaac8-d857-4b18-9d33-b81088d65e0c&utm_content=immediately

This is a caution in use only we are not accepting stock returns - if any defective stock is found it should be returned directly to the manufacturer.

Further Information

For more information or medical information queries please contact: Accord Medical Information Department on 01271 385257, email medinfo@accord-healthcare.com.

For stock control queries, please contact: Accord Customer Services Team on 0800 373573

For updated PIL requests please contact contact@accord-healthcare.com or phone: 01271 385200

August 2022 Bank Holiday Opening Hours

To help keep our customers informed of changes to our service, we have published our August 2022 Bank Holiday opening hours.

View our August 2022 Bank Holiday opening hours:

August 2022 Bank Holiday opening hours for Pharmacy and Retail customers

August 2022 Bank Holiday opening hours for Hospital customers

Class 2 Recall - Zoledronic acid SUN 5mg solution for infusion

Sun Pharmaceuticals are recalling the below batches of zoledronic acid due to out of specification results observed for Particulate Matter Test during routine stability testing. This recall is conducted as a precautionary measure as remaining vials may no longer be in line with the licensed product specification with respect to particulate matter.

MHRA drug alert date  11 August 2022

MHRA drug alert link:

https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-sun-pharmaceutical-industries-europe-bv-zoledronic-acid-sun-5mg-solution-for-infusion-el-22-a-slash-34?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=7554e8e8-c653-4070-8512-bf893507e32a&utm_content=immediately

Further Information

For more information, medical or supply enquiries, please contact:

Maciej Rosiak (Qualified Person), +31612091885; maciej.rosiak@sunpharma.com  or

Gene Kelleher (Head Quality Europe), +353 86 344 1145; gene.kelleher@sunpharma.com

Please return all affected stock to your original supplier for credit. Unfortunately, we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Service Update - extreme heat

The team at Alliance Healthcare want you and your patients to stay safe during the extreme heat.

We are doing all that we can to deliver to you while ensuring the safety of our team members and the integrity of your products.

Customers can find the latest service news on our myahportal.

Company Led Recall - Sodium Chloride Eye Drops 5% 1x10ml

Stockport Pharmaceuticals are recalling a batch of Sodium Chloride Eye Drops 5% w/v as the sterile eye droppers supplied with the medicinal product have expired (January 2022).

MHRA drug alert date: 8 August 2022

MHRA drug alert link:

https://www.gov.uk/drug-device-alerts/company-led-medicines-recall-stockport-pharmaceuticals-sodium-chloride-eye-drops-5-percent-1x10ml-unlicensed-medicine-clmr-22-a-slash-06?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=5ad08b90-ab91-4591-ba3a-222f557b2a96&utm_content=immediately

Alliance do not stock this product and therefore we are not accepting stock returns.

Company Contact for medical information enquiries

For medical information enquiries, please contact:

Emma Joy Wraith

Head of Quality Assurance

Email: Emma-joy.wraith@stockport.nhs.uk 

Company Contact for stock enquiries

For stock information enquiries, please contact:

Andrew Singleton

Head of Production

Email: Andrew.singleton@stockport.nhs.uk

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.